Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial

Background: Patient-reported outcomes (PROs), including health-related quality of life, are recommended to be routinely collected in clinical trials, but data are limited from trials of sarcoma patients. In this analysis, pooled PRO data are reported from patients with advanced or metastatic soft ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Tine, Brian A, Krarup-Hansen, Anders, Hess, Lisa M, Abdul Razak, Albiruni R, Soldatenkova, Victoria, Wright, Jennifer, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081717/
https://www.ncbi.nlm.nih.gov/pubmed/35547106
http://dx.doi.org/10.1177/20363613221100033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081717/
https://www.ncbi.nlm.nih.gov/pubmed/35547106
http://dx.doi.org/10.1177/20363613221100033

Ejemplares similares